Review of the device history records indicated no abnormalities were found.Production records show that lot met the standard requirement prior to shipment release.The lot passed all the required inspections and criteria were performed according to the established procedures.No significant changes were made to the manufacturing process.Glove formulation was modified to reduce the risk of type iv allergy by eliminating certain higher risk chemicals (mainly accelerators) from the formulation and to ensure compliance with an ever more stringent regulatory environment.Returned and retained sample analysis show no abnormalities.Fit kit test that measures major allergens was performed with no detection determined.This indicates a very low probability that the gloves could have cause an allergic reaction.Chemical residue test measuring presence of accelerators and antioxidants residue show no abnormalities were found.Based on the investigation, there were no deviations nor evidence of special causes that would have led to an allergic reaction.As a result, no corrective action was rendered at this time.
|